Not sure how you can say lacks efficacy in a refractory (ie failed treatment) group when 20% are cured?
With regards, statistical significance, with a denominator of 15 patients statistical significance is hard to achieve, however, I'm not even sure what hypothesis you're suggesting has not been demonstrated with statistical significance...
Better to be careful with the language you use, otherwise you're simply muddying the waters
Not sure how you can say lacks efficacy in a refractory (ie...
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 35499 | 1 |
View Market Depth
| Last trade - 07.00am 02/07/2024 (20 minute delay) ? |
| PTX (ASX) Chart |
Day chart unavailable